ArticleJournal of thoracic disease2017

Optimal managements of stage IIIA (N2) non-small cell lung cancer patients: a population-based survival analysis.

Zhaofei Pang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.